Health Trials

Wound Closure

2

Review clinical trials related to Wound Closure. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Using TropoCells(R) Autologous Platelet-Rich Fibrin (PRF) to Treat Chronic Non-Healing Wounds

Platelet-based therapies have been used to treat bony and soft tissue effects for more than 30 years. Tropocells® Autologous Platelet-Rich Fibrin (PRF) is being used to treat chronic, non-healing wounds, of a variety of types. This will help determine the safety and effective use of PRF in the treatment of soft tissue defects.

Participants needed: 16
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Estar Medical dba Medical Technologies, LTDUpdated: Jan 6, 2026Locations: 3
Eligibility criteria

1. Male or female ≥ 18≤ 80 years of age 2. Chronic wounds present for at least t...

Exclusion Criteria [+18]

Read more
Status: Recruiting

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

This research is studying a device already approved by the Food and Drug Administration (FDA) to treat wound closures. Researchers are studying a large group of people to continue to learn information about the safety of the STRATAFIX suture and how people's bodies react to using it over a long period of time. This research will provide additional information about using STRATAFIX sutures to close surgical wounds.

Participants needed: 160
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: University of MichiganUpdated: Nov 5, 2025Locations: 1
Eligibility criteria

Elective or emergent surgical approaches for cranial or spine neurosurgical appr...

Patients with prior surgical wound dehiscence or infection [+1]

Read more